Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases

Luo, Qiang, Chen, Leichong, Li, Zhenyu, Cheng Li, Zhang, Sijia, Zong, Yan, Li, Qianwen, Suda, Kenichi, Santarpia, Mariacarmela, Dalia, Samir, Meng, Rui
ISSN / E-ISSN
— / —
DOI
10.21037/tlcr-23-542 ↗
Volume · Issue · Pages
12 · 11 · —
Publisher
AME Publishing Company
Article URL
https://tlcr.amegroups.org/article/view/80595 ↗
Article details
Unverified
Publication date (each date has its type and source)
30 Nov 2023
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
Dates on record for this article
TypeDateSource
Publisher publication date30 Nov 2023 Journal websites (OAI-PMH feeds of Open Journal Systems)

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized W
Based on the recorded HEC dataset applicable to the article's publication date. Listed as W in the HEC list for 2023–24.
Journal
Translational Lung Cancer Research
Publication date used
30 Nov 2023 (Publisher publication date)
Applicable HEC period
2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
Category
W
Recognition status
Recognized (OK_RECORD_FOUND)
Source
HJRS 2023-24 page 959, row 6669
Verification status
Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.